Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study
Fabio Guerriero,1,2 Anna Roberto,3 Maria Teresa Greco,4 Carmelo Sgarlata,1 Marco Rollone,2 Oscar Corli3 1Department of Internal Medicine and Medical Therapy, Section of Geriatrics, University of Pavia, 2Department of Geriatrics, Agency for Elderly People of Pavia, Santa Margherita Institute, Pavia,...
Main Authors: | Guerriero F, Roberto A, Greco MT, Sgarlata C, Rollone M, Corli O |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-04-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/long-term-efficacy-and-safety-of-oxycodonendashnaloxone-prolonged-rele-peer-reviewed-article-DDDT |
Similar Items
-
Combination of oxycodone/naloxone for severe oncologic pain treatment
by: P. Desio
Published: (2011-09-01) -
Associazione ossicodone/naloxone per il trattamento del dolore oncologico severo - Combination of oxycodone/naloxone for severe oncologic pain treatment
by: Paolo Desio
Published: (2011-09-01) -
Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients
by: Guerriero F, et al.
Published: (2014-12-01) -
Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial
by: Kyung-Hee Lee, et al.
Published: (2017-09-01) -
A comparison between the administration of oral prolonged-release oxycodone-naloxone and transdermal fentanyl in patients with moderate-to-severe cancer pain: a propensity score analysis
by: Roberto A, et al.
Published: (2017-09-01)